Human ES-derived MSCs correct TNF-α-mediated alterations in a blood–brain barrier model
Abstract Background Immune cell trafficking into the CNS is considered to contribute to pathogenesis in MS and its animal model, EAE. Disruption of the blood–brain barrier (BBB) is a hallmark of these pathologies and a potential target of therapeutics. Human embryonic stem cell-derived mesenchymal s...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12987-019-0138-5 |